Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Held

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Circulation. Cardiovascular Interventions|May 11, 2016
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic SubstudyChristopher J Popma, Shi Sheng, Serge Korjian, et al.
Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
American Heart Journal|January 5, 2021
Risk markers of incident atrial fibrillation in patients with coronary heart diseaseMaria Tomasdottir, Claes Held, Nermin Hadziosmanovic, et al.
Blood|March 31, 2017
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapyRenato D Lopes, Patrícia O Guimarães, Bradley J Kolls, et al.
JACC. Cardiovascular Interventions|May 12, 2018
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary InterventionPierluigi Tricoci, L Kristin Newby, Robert M Clare, et al.
American Heart Journal|April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndromeConnie N Hess, Robert M Clare, Megan L Neely, et al.
Blood|October 17, 2014
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing proceduresDavid Garcia, John H Alexander, Lars Wallentin, et al.
Journal of the American College of Cardiology|April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and AtherosclerosisMarc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.
Blood Cells, Molecules & Diseases|July 30, 2018
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trialPierluigi Tricoci, Megan Neely, Michael J Whitley, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Circulation. Cardiovascular Interventions|May 11, 2016
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic SubstudyChristopher J Popma, Shi Sheng, Serge Korjian, et al.
Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
American Heart Journal|January 5, 2021
Risk markers of incident atrial fibrillation in patients with coronary heart diseaseMaria Tomasdottir, Claes Held, Nermin Hadziosmanovic, et al.
Blood|March 31, 2017
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapyRenato D Lopes, Patrícia O Guimarães, Bradley J Kolls, et al.
JACC. Cardiovascular Interventions|May 12, 2018
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary InterventionPierluigi Tricoci, L Kristin Newby, Robert M Clare, et al.
American Heart Journal|April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndromeConnie N Hess, Robert M Clare, Megan L Neely, et al.
Blood|October 17, 2014
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing proceduresDavid Garcia, John H Alexander, Lars Wallentin, et al.
Journal of the American College of Cardiology|April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and AtherosclerosisMarc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.
Blood Cells, Molecules & Diseases|July 30, 2018
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trialPierluigi Tricoci, Megan Neely, Michael J Whitley, et al.
Pageof 23